Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–48. https://doi.org/10.1016/s0140-6736(20)31288-5.

Article  CAS  PubMed  Google Scholar 

Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Prevent Biomark. 2016;25(1):16–27.

Article  Google Scholar 

Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584.

Article  PubMed  PubMed Central  Google Scholar 

Jung K-W, Won Y-J, Kong H-J, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat Off J Korean Cancer Assoc. 2019;51(2):417.

Google Scholar 

Sasahara M, Kanda M, Kodera YJHH. Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment. Resp Gast Cancer. 2021;36:817–32.

CAS  Google Scholar 

Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. J Med. 2006;355(1):11–20.

CAS  Google Scholar 

Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, et al. T2022 Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III. Gastric Cancer. 2022;25(1):188–96.

Article  CAS  PubMed  Google Scholar 

Deng K, Yang L, Hu B, Wu H, Zhu H, Tang CJP. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients. PLoS ONE. 2015;10(4):e0124151.

Article  PubMed  PubMed Central  Google Scholar 

Xiao J, He X, Wang Z, Hu J, Sun F, Qi F, et al. Serum carbohydrate antigen 19–9 and prognosis of patients with gastric cancer. Tumor Biol. 2014;35(2):1331–4.

Article  CAS  Google Scholar 

Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long Z, et al. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol. 2010;102(3):249–55.

Article  PubMed  Google Scholar 

Guo L, Guo X, Jiang J, Zhang J, Ji J, Liu B, et al. Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer. J Pathol. 2010;39(7):436–41.

Google Scholar 

Lu J, Dai Y, Xie J-W, Wang J-B, Lin J-X, Chen Q-Y, et al. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution. BMC Cancer. 2019;19(1):1–9.

Article  Google Scholar 

Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V, et al. Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: a multicenter retrospective study. J Surg Oncol. 2019;119(7):948–57.

Article  PubMed  Google Scholar 

Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi H, Na KJJT. Integrative analysis of imaging and transcriptomic data of the immune landscape associated with tumor metabolism in lung adenocarcinoma. Clin Prog Implicat. 2018;8(7):1956.

CAS  Google Scholar 

Chung HW. Lim J-BJWjogW Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. J Gastroenterol. 2014;20(7):1667.

CAS  Google Scholar 

Barrett RL, Puré EJE. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife. 2020;9:e57243.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nissen NI, Karsdal M, Willumsen N. Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology. J Exp Clin Cancer Res. 2019;38(1):115. https://doi.org/10.1186/s13046-019-1110-6.

Article  PubMed  PubMed Central  Google Scholar 

Zhou ZH, Ji CD, Xiao HL, Zhao HB, Cui YH, Bian XW. Reorganized collagen in the tumor microenvironment of gastric cancer and its association with prognosis. J Cancer. 2017;8(8):1466–76. https://doi.org/10.7150/jca.18466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17(1):309. https://doi.org/10.1186/s12967-019-2058-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q, et al. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut. 2012;61(7):977–85.

Article  CAS  PubMed  Google Scholar 

Bertoli G, Cava C. Castiglioni IJIjoms MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer. Gut. 2016;17(3):421.

Google Scholar 

Matsuoka T. Yashiro MJWjog biomarkers of gastric cancer: current topics and future perspective. World J Gastroenterol. 2018;24(26):2818.

Article  PubMed  PubMed Central  Google Scholar 

Zhao J, Yang S, Lv C, Liu YJAJOPCP. Cancer associated fibroblasts suppressed ferroptosis in glioblastoma via up-regulating lncRNA. Amer J Phys Cell Phys. 2023;325:1039.

Google Scholar 

Li G, Peng L, Wu M, Zhao Y, Cheng Z, Li GJFiI. Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.1039510.

Article  PubMed  PubMed Central  Google Scholar 

Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Cancer systems biology: Springer; 2018. p. 243–59.

Google Scholar 

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):1–20.

Google Scholar 

Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. https://doi.org/10.1186/1471-2105-14-7.

Article  Google Scholar 

Zou Y, Xie J, Zheng S, Liu W, Tang Y, Tian W, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg. 2022;107:106936.

Article  PubMed  Google Scholar 

Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer GJNRI. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97–111.

Article  CAS  PubMed  Google Scholar 

Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A. Taieb JJWJoGW Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araki I, Hosoda K, Yamashita K, Katada N, Sakuramoto S, Moriya H, et al. Prognostic impact of venous invasion in stage IB node-negative. Gastric Cancer. 2015;18:297–305.

Article  PubMed  Google Scholar 

Zhao B, Lv W, Mei D, Luo R, Bao S, Huang B, et al. Perineural invasion as a predictive factor for survival outcome in gastric cancer patients: a systematic review and meta-analysis. J Clin Pathol. 2020;73(9):544–51.

Article  CAS  PubMed  Google Scholar 

Li H, Liu Z, Xu C, Chen Y, Zhang J, Cui B, et al. Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients. Oncol Letters. 2013;5(5):1485–90.

Article  CAS  Google Scholar 

Ling Z, Li R. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis. Int J Biol Markers. 2014;29(2):e99–111. https://doi.org/10.5301/jbm.5000054.

Article  CAS  PubMed  Google Scholar 

Hanahan DJCd. Hallmarks of cancer. New Dimen. 2022;12(1):31–46.

CAS  Google Scholar 

Cairns RA, Harris IS, Mak TWJNRC. Regulation of cancer cell metabolism. Nature Rev Cancer. 2011;11(2):85–95.

Article  CAS  Google Scholar 

Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202.

Article  Google Scholar 

Cristescu R, Lee J, Nebozhyn M, Kim K-M, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449–56.

Article  CAS  PubMed  Google Scholar 

Bang Y-J, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. The Lancet. 2010;376(9742):687–97.

Article  CAS  Google Scholar 

Chen D, Chen G, Jiang W, Fu M, Liu W, Sui J, et al.